ArticleBMC medicine2026

Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis.

Fan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.